CRISPR/Cas9 editing of HIV-1 transcription factor binding sites on the 5' long terminal repeats to permanently inactivate latent provirus - B. Wigdahl; C.-H. Chung; A.G. Allen; A.J. Atkins; R. Costello; N.T. Sullivan; M.R. Nonnemacher; W.N. Dampier (Elsevier, 2019)